PuSH - Publication Server of Helmholtz Zentrum München

Sulaj, A.* ; Zemva, J.* ; Zech, U.* ; Woehning, A.* ; Brune, M.* ; Rudofsky, G.* ; Nawroth, P.P. ; Fleming, T.* ; von Bauer, R.*

The effect of lifestyle intervention in obesity on the soluble form of activated leukocyte cell adhesion molecule.

BMC Endocr. Disord. 16:56 (2016)
Publ. Version/Full Text DOI
Open Access Gold
Creative Commons Lizenzvertrag
Background: The aim of this study was to investigate the effect of a lifestyle intervention in obesity on the soluble form of the activated leukocyte cell adhesion molecule (sALCAM) and its association with metabolic parameters. Methods: Twenty-nine obese subjects selected from the OPTIFAST (R) 52 program. This program consisted into 2 crucial phases: an initial 12-week active weight reduction phase, followed by a 40-week weight maintenance phase. At baseline, after 12 weeks and at the end of the program, fasting glucose and insulin, total cholesterol, LDL-C, HDL-C, triglycerides, adiponectin, leptin, high sensitivity CRP, sALCAM, homeostasis model assessment-estimated insulin resistance (HOMA-IR) and leptin-to-adiponectin-ratio were determined. Oral glucose tolerance test (OGTT) was performed when indicated. Results: At baseline, the serum concentration of sALCAM was increased and correlated positively with HOMA-IR and negatively with age. At the end of the program, sALCAM concentrations decreased significantly. Multivariate analysis showed that sALCAM significantly correlated with age, glucose concentration after 2 h OGTT and the HOMA-IR. A higher decrease of HOMA-IR during the study was observed in subjects with higher concentration of sALCAM at baseline. Conclusions: sALCAM might be a novel biomarker in obesity that correlates and predicts insulin sensitivity improvement and that can be affected by lifestyle intervention.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords Obesity ; Lifestyle Intervention ; Insulin Resistance ; Salcam ; Cell Adhesion Molecule; Insulin-resistance; Potential Biomarker; Weight-loss; Cancer; Sensitivity; Serum
ISSN (print) / ISBN 1472-6823
e-ISSN 1472-6823
Journal BMC Endocrine Disorders
Quellenangaben Volume: 16, Issue: , Pages: , Article Number: 56 Supplement: ,
Publisher BioMed Central
Publishing Place London
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Institute of Diabetes and Cancer (IDC)